Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists probe mystery skin rash with existing drug

NCT ID NCT06012448

Summary

This study tested whether dupilumab, an existing injectable medication, could help people with chronic unexplained skin rashes. Researchers enrolled 10 participants to understand how the drug affects the immune system and whether it reduces rash severity and itching. The main goal was to learn why these rashes occur and how the treatment might work.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMAL HYPERSENSITIVITY REACTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

Conditions

Explore the condition pages connected to this study.